Publications: Nina A. Hering
home page home page2025
Masete KV, Günzel D, Schulzke JD, Epple HJ*, Hering NA* (*shared last authorship) (2025) Matrix-free human 2D organoids recapitulate duodenal barrier and transport properties. BMC Biol. 23(1): 2 (13 pages). doi: 10.1186/s12915-024-02105-7 (°IF 4.4)
2024
Speichinger F, Gratl A, Raude B, Schawe L, Carstens J, Hering NA, Greiner A, Pesta D, Frese JP (2024) Mitochondrial respiration in peripheral arterial disease depends on stage severity.
2023
Hering NA, Günzler E, Arndt M, Zibell M, Lauscher JC, Kreis ME, Beyer K, Seeliger H, Pozios I (2023) Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer.
Berg AK, Hahn EM, Speichinger-Hillenberg F, Grube AS, Hering NA, Stoyanova AK, Beyer K (2023) The Impact of TRAIL on the Immunological Milieu during the Early Stage of Abdominal Sepsis.
Hader H, Hering NA, Schulzke JD, Bücker R, Rosenthal R (2023) Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells.
Front. Pharmacol. 14: 1301800 (11 pages).
doi: 10.3389/fphar.2023.1301800
(°IF 4.4)
Lee LD, Hering NA, Zibell M, Lobbes LA, Kamphues C, Lauscher JC, Margonis GA, Seeliger H, Beyer K, Weixler B, Pozios I (2023) Near-infrared
Fluorescence Imaging for Detecting Pancreatic Liver Metastasis in an Orthotopic Athymic Mouse Model.
Lobbes LA, Schütze MA, Droeser R, Arndt M, Pozios I, Lauscher JC, Hering NA, Weixler B (2023) Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma-An Unexpected Correlation to Guide Future Treatment?
Pozios I, Hering NA, Guenzler E, Arndt M, Elezkurtaj S, Knösel T, Bruns CJ, Margonis GA, Beyer K, Seeliger H (2023) Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144.
Stoyanova AK, Sattler A, Hahn EM, Hering NA, Arndt M, Lauscher JC, Speichinger-Hillenberg F, Kotsch K, Berg AK, Beyer K (2ß23) Immune Phenotypic Characterization of a TRAIL-Knockout Mouse.
2022
Schawe L, Raude B, Carstens JC, Hinterseher I, Hein RD, Omran S, Berger G, Hering NA, Buerger M, Greiner A, Frese JP (2022) Effect of Revascularization on Intramuscular Vascular Endothelial Growth Factor Levels in Peripheral Arterial Disease.
2021
Hering NA, Liu V, Kim R, Weixler B, Droeser RA, Arndt M, Pozios I, Beyer K, Kreis ME, Seeliger H (2021) Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma.
Hering NA, Luettig J, Jebautzke B, Schulzke JD, Rosenthal R (2021) The punicalagin metabolites ellagic acid and urolithin A exert different strengthening and anti-inflammatory effects on tight junction-mediated intestinal barrier function in vitro. Front. Phamacol. 12: 610164, doi: 10.3389/fphar.2021.610164 (IF 6.0)
Hartmann L, Arndt M, Hahn EM, Mueller MH, Kreis ME, Hering NA (2021) Effect of bowel preparation on intestinal permeability and inflammatory response during postoperative ileus in mice.
2019
Hering NA, Fromm A, Bücker R, Gorkiewicz G, Zechner EL, Högenauer C, Fromm M, Schulzke JD, Troeger H (2019) Tilivalline- and tilimycin-independent effects of Klebsiella oxytoca on tight junction-mediated intestinal barrier impairment. Int. J. Mol. Sci. 20(22): 5595 (16 pages) (IF 4.6) [PubMed] [WebPage] [PDF]
Subramaniam S, Müller VS, Hering NA, Mollenkopf H, Becker D, Heroven AK, Dersch P, Pohlmann A, Tedin K, Porwollik S, McClelland M, Meyer TF, Hunke S. (2019) Contribution of the Cpx envelope stress system to metabolism and virulence regulation in Salmonella enterica serovar Typhimurium. PLoS One 14(2): e0211584, Erratum in 14(2): e0213297 (IF 2.7) [PubMed] [WebPage] [PDF]
2018
Bücker R, Krug SM, Moos V, Bojarski C, Schweiger MR, Kerick M, Fromm A, Janßen S, Fromm M, Hering NA, Siegmund B, Schneider T, Barmeyer C, Schulzke JD (2018) Campylobacter jejuni impairs sodium transport and epithelial barrier function via cytokine release in human colon. Mucosal Immunol. 11(2): 474-485 (IF 7.4) [PubMed] [DOI] [PDF] [Supplement1] [Supplement2]
Troeger H, Hering NA, Bojarski C, Fromm A, Barmeyer C, Uharek L, Siegmund B, Fromm M, Rieger K*, Schulzke JD* (*shared last authorship) (2018) Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease. Bone Marrow Transplant.
2017
Hering NA, Luettig J, Krug SM, Wiegand S, Gross G, van Tol EA, Schulzke JD*, Rosenthal R* (*shared last authorship) (2017) Lactoferrin protects against intestinal inflammation or bacteria-induced barrier dysfunction in vitro. Ann. N.Y. Acad. Sci. 1405: 177-188 (IF 4.3) [PubMed] [WebPage] [PDF]
2016
Hering NA, Fromm A, Kikhney J, Lee IM, Moter A, Schulzke JD, Bücker R (2016) Yersinia enterocolitica affects intestinal barrier function in the colon. J. Infect. Dis. 213(7): 1157-1162 (IF 6.3) [PubMed] [WebPage] [PDF]
Rosenthal R, Luettig J, Hering NA, Krug SM, Albrecht U, Fromm M, Schulzke JD (2017) Myrrh exerts barrier-stabilizing and -protective effects in HT-29/B6 and Caco-2 intestinal epithelial cells. Int. J. Colorectal Dis. 32(5): 623-634 (IF 2.4) [PubMed] [WebPage] [PDF]
2014
Hering NA*, Richter JF* (*shared first authorship), Fromm A, Wieser A, Hartmann S, Günzel D, Bücker R, Fromm M, Schulzke JD° (°corresponding author), Troeger H (2014) TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signalling in HT-29/B6 cells. Mucosal Immunol. 7(2): 369-378 (IF 7.4) [PubMed] [WebPage] [PDF]
Whelan RA*, Rausch S* (*shared first authorship), Ebner F, Günzel D, Richter JF, Hering NA, Schulzke JD, Kühl AA, Keles A, Janczyk P, Nöckler K, Wieler LH, Hartmann S (2014) A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation. Mol. Ther. 22(10): 1730-1740 (IF 6.2) [PubMed] [WebPage] [PDF]
2012
20
11Hering NA*, Andres S* (*shared first authorship), Fromm A, van Tol EA, Amasheh M, Mankertz J, Fromm M, Schulzke JD (2011) Transforming growth factor b, a whey protein component, strengthens the intestinal barrier by upregulating claudin-4 in HT-29/B6 cells. J. Nutr. 141(5): 783-789 (IF 3.9) [PubMed] [WebPage] [PDF]
Hering NA, Richter JF, Krug SM, Günzel D, Fromm A, Bohn E, Rosenthal R, Bücker R, Fromm M, Troeger H, Schulzke JD (2011) Yersinia enterocolitica induces epithelial barrier dysfunction through regional tight junction changes in colonic HT-29/B6 cell monolayers. Lab. Invest. 91(2): 310-324 (IF 3.6) [PubMed] [WebPage] [PDF] [Supplement DOC]
Nielsen HL, Nielsen H, Ejlertsen T, Engberg J, Günzel D, Zeitz M, Hering NA, Fromm M, Schulzke JD, Bücker R (2011) Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells. Plos
2009
Review
Hering NA, Schulzke JD (2009) Therapeutic options to modulate barrier defects in inflammatory bowel disease. Dig. Dis. 27(4): 450-454 (IF 1.5) [PubMed]
Diploma Thesis
Hering NA (2010) Die epitheliale Barriere als Zielstruktur pathogener und probiotischer Bakterien: Wirkmechanismen von Y. enterocolitica und E. coli Nissle. Dissertation, Biologie, FU Berlin, 14.12.10 Dr. rer. nat., Magna cum laude
Hering NA (geb. Otto) (2005) Untersuchung der Rolle des Cpx-Sensor-Regulatorsystems für die Pathogenität von Salmonella typhimurium. Diploma thesis [Biology, Humboldt University Berlin, supervision Schneider E (Faculty of Mathematics and Natural Sciences I, Institute of Biology)]